Please use this identifier to cite or link to this item:
|Title:||Expressions of SE-1, CD31 and CD105 in the vascular endothelial cells and serum of rat with hepatocellular carcinoma||Authors:||Wang, J.-Y.
Enzyme-linked immunosorbent assay
|Issue Date:||20-Mar-2010||Citation:||Wang, J.-Y., Xu, X.-Y., Jia, J.-H., Wu, C.-H., Ge, R.-W. (2010-03-20). Expressions of SE-1, CD31 and CD105 in the vascular endothelial cells and serum of rat with hepatocellular carcinoma. Chinese Medical Journal 123 (6) : 730-733. ScholarBank@NUS Repository. https://doi.org/10.3760/cma.j.issn.0366-6999.2010.06.017||Abstract:||Background: Hepatocellular carcinoma (HCC) is one of the deadliest cancers worldwide. In order to investigate the molecular biologic mechanism of HCC's development, we studied the expressions of SE-1, CD105 and CD31 in tumor endothelial cells (TECs) of HCC and in the serum of rats. Methods: We analyzed the expressions of SE-1, CD31 and CD105 in rat HCC tumor tissues using immunohistochemistry (IHC). Twenty HCC bearing rats and eighteen normal rats were examined for the expressions of SE-1, CD31 and CD105 antigens in serum by enzyme-linked immunosorbent assay (ELISA). Results: SE-1, CD31 and CD105 antigens were detected both in HCC tissue and in normal liver tissue with higher expressions of CD31 and CD105 in HCC while the SE-1 antigen expression was higher in normal liver. Similarly, serum CD31 and CD105 in rats with HCC were significantly increased compared with normal rats (t=2.8628, P=0.0086; t=4.4922, P||Source Title:||Chinese Medical Journal||URI:||http://scholarbank.nus.edu.sg/handle/10635/100656||ISSN:||03666999||DOI:||10.3760/cma.j.issn.0366-6999.2010.06.017|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.